Strong Cresemba (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea Allschwil, Switzerland, March 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that …